Altor BioScience Corporation (Altor)

Oncology Corporate Profile

HQ Location

2810 North Commerce Parkway
Miramar, FL 33025

Company Description

Altor is a privately-held biotechnology company developing targeted immunotherapeutics for treating cancer, viral infections, and inflammatory diseases based on its proprietary, integrated technologies for creation of soluble TCRs.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
ALT-801 (+ cisplatin)p53-TCR/IL-2 fusion protein1st line metastatic MelanomaII
ALT-801 (+ cisplatin and gemcitabine)p53-TCR/IL-2 fusion protein1st line metastatic Urothelial cancerII
ALT-801p53-TCR/IL-2 fusion proteinBladder cancerII
ALT-801p53-TCR/IL-2 fusion proteinMultiple MyelomaII
ALT-803IL-15 Superagonist ComplexBladderI
ALT-836 (+ gemcitabine)anti-tissue factor monoclonal antibodyMelanomaI
ALT-803IL-15 Superagonist ComplexMultiple MyelomaI
ALT-836 (+ gemcitabine)anti-tissue factor monoclonal antibodyVarious cancer typesIGenentech / Roche

View additional information on product candidates here »


Recent News Headlines

There are no news items to display